STOCK TITAN

Lifemd, Inc. - LFMDP STOCK NEWS

Welcome to our dedicated page for Lifemd news (Ticker: LFMDP), a resource for investors and traders seeking the latest updates and insights on Lifemd stock.

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (symbol: LFMDP) is backed by a company that offers a comprehensive telemedicine solution connecting physicians, medical providers, pharmacists, and patients worldwide. Their platform is HIPAA-compliant and encrypted, allowing for secure interactions and management of medical conditions. In addition to telehealth services, they also provide mobile diagnostic telehealth equipment and sell nutritional supplements and over-the-counter products. With a focus on virtual primary care, LifeMD is committed to providing accessible, high-quality healthcare services.

Rhea-AI Summary

LifeMD, Inc. announced the appointment of Dr. Calum MacRae, a renowned clinician and researcher at Harvard Medical School, to its Board of Directors. Dr. MacRae's expertise in cardiology and chronic disease management will enhance the company's virtual primary care services. His track record in implementing innovative solutions and leveraging technology in healthcare is expected to drive LifeMD's growth and improve patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
management
-
Rhea-AI Summary
LifeMD, Inc. (LFMD) will report its financial results for the first quarter of 2024 on May 8, 2024. The leading provider of virtual primary care services will host a conference call at 4:30 p.m. Eastern time to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.37%
Tags
conferences earnings
-
Rhea-AI Summary
LifeMD, Inc. (Nasdaq: LFMD) will be participating in several investor and industry conferences in May, including the BTIG Obesity Health Forum, Citizens JMP Securities Life Sciences Conference, and Obesity+Health Conference. Management will present corporate overviews, participate in panels, and hold one-on-one meetings with investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.05%
Tags
conferences
Rhea-AI Summary
LifeMD, Inc. (LFMD) declares a cash dividend for its Series A Preferred Stock, offering $0.5546875 per share to holders, payable on April 15, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
dividends
-
Rhea-AI Summary
LifeMD, Inc. (LFMD) to participate in the 23rd Annual Needham Virtual Healthcare Conference, presenting corporate overview and meeting investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.14%
Tags
conferences
-
Rhea-AI Summary
LifeMD, Inc. (LFMD) reports impressive financial results for Q4 2023 with a 60% revenue increase to $44.9 million and adjusted EPS of $0.15 per share. Telehealth revenues surged 90%, and Weight Management subscribers exceeded 22,000. The company experienced record growth in telehealth and profitability, leading to an adjusted EBITDA of $5.5 million. LifeMD raised its 2024 revenue guidance to at least $200 million, indicating a 31% growth. The company is well-positioned for expansion and aims to maintain its market disruption in telemedicine.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.26%
Tags
Rhea-AI Summary
LifeMD, Inc. (LFMD) will announce financial results for Q4 and full year 2023 on March 11, 2024. The conference call will be held at 4:30 p.m. Eastern time. Investors can dial in to listen to the call or access the webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.22%
Tags
conferences earnings
-
Rhea-AI Summary
LifeMD, Inc. (LFMD) announced participation in multiple investor conferences and a webinar to discuss GLP-1s. CEO Justin Schreiber will be presenting at various events to engage with investors and analysts.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.25%
Tags
conferences
-
Rhea-AI Summary
LifeMD, Inc. (LFMD) will participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13-14, 2024, at the Cliff Lodge in Snowbird, Utah. The company will hold one-on-one meetings during the conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.05%
Tags
conferences
Rhea-AI Summary
LifeMD, Inc. (LFMD) will participate in the Maxim Group 2024 Healthcare IT Virtual Conference on January 24-25, 2024. The company's management will engage in a virtual fireside chat and one-on-one meetings, offering investors an opportunity to engage with the company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.06%
Tags
conferences

FAQ

What is the current stock price of Lifemd (LFMDP)?

The current stock price of Lifemd (LFMDP) is $22.315 as of February 21, 2025.

What does LifeMD, Inc. offer?

LifeMD offers a comprehensive telemedicine solution connecting physicians, medical providers, pharmacists, and patients worldwide.

Is LifeMD's platform secure?

Yes, LifeMD's platform is HIPAA-compliant and all interactions are encrypted for security.

What products does LifeMD sell?

In addition to telehealth services, LifeMD sells nutritional supplements and over-the-counter products.

What is the focus of LifeMD's services?

LifeMD is focused on providing virtual primary care to make high-quality healthcare accessible for all.

How does LifeMD contribute to the healthcare industry?

LifeMD's telemedicine platform and services aim to improve patient outcomes and provide more convenient access to healthcare.
Lifemd, Inc.

Nasdaq:LFMDP

LFMDP Rankings

LFMDP Stock Data

1.40M
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States
NEW YORK